← Leaderboards
Rachel Ann Bender Ignacio
University Of Washington
$1,198,672
Attributed
$1,198,672
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $304.7K · FY2017–22$500K$375K$250K$125K$0
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$1,198,672 · 3
By mechanism
K23$868,341 · 1
R21$330,330 · 1
U01$1 · 1
Top collaborators
- Rodney J.Y. Ho1 shared
Most similar at University Of Washington
Same institution · by research overlap
- King Kennard Holmes$42,208,763
- David L Tirschwell$8,538,743
- Geoffrey Scott Gottlieb$16,750,227
- Lisa M Frenkel$29,105,317
- Rodney J.y. Ho$31,444,678
Others in their field
Other Emerging Leaders on “Antiretroviral Therapy”
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$29,616,650
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$29,269,420
- Jacob D Estes · Oregon Health & Science University$15,457,863
- Wilton B Williams · Duke University$15,417,829
- Mohamed Abdel Mohsen · Wistar Institute$11,459,215
Research focus
Antiretroviral TherapyPersonsDesignDiagnosisImmuneVisitRandomizedHiv InfectionsQuestionnairesImmune ActivationHigh RiskTechnologyEnrollmentResponseSamplingPlasmaCohortCellsInnovationLeadParticipantCytokineAids PreventionEpidemiology
Grant awards (8)
Addressing the burden of untreated HIV in cancer patients in sub-Saharan Africa: feasibility and planning for a pragmatic clinical trial$167,928
R21 · FY2022 · AI · contact PI
"NextGen Long-acting Platform: Targeted Combination Antiretrovirals"$1
U01 · FY2022 · AI · contact PI
Addressing the burden of untreated HIV in cancer patients in sub-Saharan Africa: feasibility and planning for a pragmatic clinical trial$162,402
R21 · FY2021 · AI · contact PI
Determining the component causes of systemic immune activation that moderate HIV acquisition and establishment of the latent viral reservoir$142,285
K23 · FY2021 · AI · contact PI
Determining the component causes of systemic immune activation that moderate HIV acquisition and establishment of the latent viral reservoir$180,805
K23 · FY2020 · AI · contact PI
Determining the component causes of systemic immune activation that moderate HIV acquisition and establishment of the latent viral reservoir$180,814
K23 · FY2019 · AI · contact PI
Determining the component causes of systemic immune activation that moderate HIV acquisition and establishment of the latent viral reservoir$181,801
K23 · FY2018 · AI · contact PI
Determining the component causes of systemic immune activation that moderate HIV acquisition and establishment of the latent viral reservoir$182,636
K23 · FY2017 · AI · contact PI